AVIR
Price
$3.45
Change
-$0.08 (-2.27%)
Updated
Jun 27 closing price
Capitalization
293.97M
38 days until earnings call
IMNM
Price
$8.77
Change
-$0.02 (-0.23%)
Updated
Jun 27 closing price
Capitalization
763.97M
45 days until earnings call
Interact to see
Advertisement

AVIR vs IMNM

Header iconAVIR vs IMNM Comparison
Open Charts AVIR vs IMNMBanner chart's image
Atea Pharmaceuticals
Price$3.45
Change-$0.08 (-2.27%)
Volume$444.47K
Capitalization293.97M
Immunome
Price$8.77
Change-$0.02 (-0.23%)
Volume$1.07M
Capitalization763.97M
AVIR vs IMNM Comparison Chart in %
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. IMNM commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Buy and IMNM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (AVIR: $3.45 vs. IMNM: $8.77)
Brand notoriety: AVIR and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 107% vs. IMNM: 120%
Market capitalization -- AVIR: $293.97M vs. IMNM: $763.97M
AVIR [@Biotechnology] is valued at $293.97M. IMNM’s [@Biotechnology] market capitalization is $763.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, AVIR is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 3 bullish TA indicator(s).

  • AVIR’s TA Score: 5 bullish, 3 bearish.
  • IMNM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AVIR is a better buy in the short-term than IMNM.

Price Growth

AVIR (@Biotechnology) experienced а +6.15% price change this week, while IMNM (@Biotechnology) price change was +0.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

AVIR is expected to report earnings on Aug 06, 2025.

IMNM is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($764M) has a higher market cap than AVIR($294M). AVIR YTD gains are higher at: 2.985 vs. IMNM (-17.420). AVIR has higher annual earnings (EBITDA): -161.77M vs. IMNM (-175.18M). AVIR has more cash in the bank: 425M vs. IMNM (317M). AVIR has less debt than IMNM: AVIR (1.45M) vs IMNM (4.77M). IMNM has higher revenues than AVIR: IMNM (10.9M) vs AVIR (0).
AVIRIMNMAVIR / IMNM
Capitalization294M764M38%
EBITDA-161.77M-175.18M92%
Gain YTD2.985-17.420-17%
P/E RatioN/AN/A-
Revenue010.9M-
Total Cash425M317M134%
Total Debt1.45M4.77M30%
FUNDAMENTALS RATINGS
AVIR: Fundamental Ratings
AVIR
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVIRIMNM
RSI
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSUMF10.050.20
+2.03%
FORTESCUE LTD.
INPOY8.310.01
+0.18%
InPost S A
ECIA0.37N/A
N/A
Encision, Inc.
ALGEF0.02N/A
N/A
ALLIGATOR ENERGY LTD.
BDGIF34.52-0.37
-1.06%
Badger Infrastructure Solutions Ltd

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with IMNM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-2.27%
IMNM - AVIR
47%
Loosely correlated
-0.23%
XENE - AVIR
46%
Loosely correlated
+0.62%
MGTX - AVIR
45%
Loosely correlated
-0.90%
FHTX - AVIR
43%
Loosely correlated
-0.41%
VNDA - AVIR
43%
Loosely correlated
-0.83%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.23%
IDYA - IMNM
61%
Loosely correlated
-4.13%
ARWR - IMNM
56%
Loosely correlated
+0.06%
BEAM - IMNM
55%
Loosely correlated
-1.98%
RXRX - IMNM
55%
Loosely correlated
-6.85%
SYRE - IMNM
54%
Loosely correlated
-4.99%
More